Sunshine Biopharma Inc (SBFM) Stock Analysis

Sunshine Biopharma Inc (SBFM) is a publicly traded company in the HEALTHCARE sector. It trades at $2.60, carries a market capitalization of $3.86M. This page summarizes the public market data, fundamentals, and frequently asked questions for SBFM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Sunshine Biopharma Inc currently has a Neutral sentiment score of 0.03.

About Sunshine Biopharma Inc

Sunshine Biopharma Inc. is a Canadian pharmaceutical company dedicated to the development and commercialization of innovative anticancer therapeutics. Based in Pointe-Claire, Quebec, the company is committed to addressing unmet medical needs in oncology through its proprietary drug candidates, which leverage cutting-edge science and research. With a robust pipeline aimed at delivering effective treatments for various forms of cancer, Sunshine Biopharma is positioned to make significant contri...

GNG Research Analysis

GNG Research scores Sunshine Biopharma Inc (SBFM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SBFM.

Frequently Asked Questions

Does SBFM pay dividends?

Sunshine Biopharma Inc (SBFM) does not currently pay a regular dividend.

What is SBFM's market cap?

Sunshine Biopharma Inc (SBFM) has a market capitalization of $3.86M with a current stock price of $2.60.